Surgery for recurrent or persistent disease · adults with growth‐hormone secreting pituitary adenomas
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Complications of surgery (2–10 years) · people with non‐severe primary valvular incompetence
1 finding from 1 review
Clinical changes (CEAP classification scoring for clinical outcomes after surgery) (3 years) · people with non‐severe primary valvular incompetence
1 finding from 1 review
Repeat surgery (or pessary) for recurrent prolapse · women undergoing pelvic organ prolapse surgery
Pelvic floor muscle training before and after prolapse surgery showed no clear difference in repeat surgery (or pessary) for recurrent prolapse compared with no training (low certainty).
1 finding from 1 review
Serious adverse events measured by surgery or procedure‐related complications within 30 days ‐ not reported · patients undergoing non‐cardiac surgery/invasive procedures
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Clinical improvement ‐ Long‐term improvement: > 3 months · carpal tunnel syndrome
Surgery probably leads to higher clinical improvement ‐ Long‐term improvement: > 3 months compared with splint (moderate certainty).
1 finding from 1 review
Function ‐ Long‐term improvement: > 3 months · carpal tunnel syndrome
1 finding from 1 review
Pain VAS 0‐100 (higher means worse) · carpal tunnel syndrome
1 finding from 1 review
Health‐related quality of life ‐ Long‐term improvement: > 3 months · carpal tunnel syndrome
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Adverse effects · carpal tunnel syndrome
It is very uncertain whether surgery changes adverse effects compared with corticosteroid injection (very low certainty).
1 finding from 1 review
CTS symptoms (Boston CTS questionnaire) ‐ long‐term improvement: > 3 monthsScale: 1 to 5, higher is worse · carpal tunnel syndrome
1 finding from 1 review
Function (Boston CTS questionnaire) ‐ Long‐term improvement: > 3 monthsScale: 1 to 5, higher is worse · carpal tunnel syndrome
1 finding from 1 review
Pain ‐ Long‐term improvement: > 3 months · carpal tunnel syndrome
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Health‐related quality of life (EQ‐5D) ‐ Long‐term improvement: > 3 months Scale: 0 to 1, higher is better · carpal tunnel syndrome
1 finding from 1 review
Adverse effects · carpal tunnel syndrome
It is very uncertain whether surgery changes adverse effects compared with splint (very low certainty).
1 finding from 1 review
Clinical improvement ‐ Long‐term improvement: > 3 months · carpal tunnel syndrome
It is very uncertain whether surgery changes clinical improvement ‐ Long‐term improvement: > 3 months compared with corticosteroid injection (very low certainty).
1 finding from 1 review
Symptoms ‐ Long‐term improvement: > 3 months · carpal tunnel syndrome
1 finding from 1 review
Adverse events associated with treatment · Adults with oropharyngeal cancer
1 finding from 1 review
Adverse events: grade 2+ treatment-related events similar (31/34 radiotherapy vs 33/34 surgery; RR 0.94, 0.83 to 1.06); more hearing loss/neutropenia/constipation/tinnitus with radiotherapy, more oral bleeding/trismus…
1 study · 68 participants
Very low
Total mortality · Adults with oropharyngeal cancer
Surgery showed no clear difference in total mortality compared with radiotherapy alone (low certainty).
1 finding from 1 review
Locoregional recurrence · Adults with oropharyngeal cancer
The review found no eligible studies for this question.
1 finding from 1 review